334 related articles for article (PubMed ID: 33013819)
1. Immune Effects of γδ T Cells in Colorectal Cancer: A Review.
Ma R; Yuan D; Guo Y; Yan R; Li K
Front Immunol; 2020; 11():1600. PubMed ID: 33013819
[TBL] [Abstract][Full Text] [Related]
2. TCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets.
Reis BS; Darcy PW; Khan IZ; Moon CS; Kornberg AE; Schneider VS; Alvarez Y; Eleso O; Zhu C; Schernthanner M; Lockhart A; Reed A; Bortolatto J; Castro TBR; Bilate AM; Grivennikov S; Han AS; Mucida D
Science; 2022 Jul; 377(6603):276-284. PubMed ID: 35857588
[TBL] [Abstract][Full Text] [Related]
3. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
4. NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer.
Mikulak J; Oriolo F; Bruni E; Roberto A; Colombo FS; Villa A; Bosticardo M; Bortolomai I; Lo Presti E; Meraviglia S; Dieli F; Vetrano S; Danese S; Della Bella S; Carvello MM; Sacchi M; Cugini G; Colombo G; Klinger M; Spaggiari P; Roncalli M; Prinz I; Ravens S; di Lorenzo B; Marcenaro E; Silva-Santos B; Spinelli A; Mavilio D
JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31689241
[TBL] [Abstract][Full Text] [Related]
5. Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity.
Lopes N; Silva-Santos B
Eur J Immunol; 2021 Jan; 51(1):17-26. PubMed ID: 33188652
[TBL] [Abstract][Full Text] [Related]
6. Editorial: γδ T Cells in Cancer.
Coffelt SB; Kabelitz D; Silva-Santos B; Kuball J; Born W; Bank I
Front Immunol; 2020; 11():602411. PubMed ID: 33329597
[No Abstract] [Full Text] [Related]
7. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
Rei M; Pennington DJ; Silva-Santos B
Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
[TBL] [Abstract][Full Text] [Related]
8. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
[TBL] [Abstract][Full Text] [Related]
9. γδ T cells in cancer immunotherapy.
Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
[TBL] [Abstract][Full Text] [Related]
10. The role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapy.
Van Acker HH; Campillo-Davo D; Roex G; Versteven M; Smits EL; Van Tendeloo VF
Cytokine Growth Factor Rev; 2018 Jun; 41():54-64. PubMed ID: 29773448
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy accelerates immune-senescence and functional impairments of Vδ2
Bruni E; Cazzetta V; Donadon M; Cimino M; Torzilli G; Spata G; Leonardi G; Dieli F; Mikulak J; Mavilio D
J Immunother Cancer; 2019 Dec; 7(1):347. PubMed ID: 31829255
[TBL] [Abstract][Full Text] [Related]
12. Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.
Schilbach K; Frommer K; Meier S; Handgretinger R; Eyrich M
J Immunother; 2008; 31(9):896-905. PubMed ID: 18832998
[TBL] [Abstract][Full Text] [Related]
13. Contemplating Dichotomous Nature of Gamma Delta T Cells for Immunotherapy.
Bhat J; Placek K; Faissner S
Front Immunol; 2022; 13():894580. PubMed ID: 35669772
[TBL] [Abstract][Full Text] [Related]
14. Complex role of γδ T-cell-derived cytokines and growth factors in cancer.
Ramstead AG; Jutila MA
J Interferon Cytokine Res; 2012 Dec; 32(12):563-9. PubMed ID: 23078623
[TBL] [Abstract][Full Text] [Related]
15. CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation.
Reyes RM; Deng Y; Zhang D; Ji N; Mukherjee N; Wheeler K; Gupta HB; Padron AS; Kancharla A; Zhang C; Garcia M; Kornepati AVR; Boyman O; Conejo-Garcia JR; Svatek RS; Curiel TJ
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33849925
[TBL] [Abstract][Full Text] [Related]
16. Circulating CD103
Risnes LF; Eggesbø LM; Zühlke S; Dahal-Koirala S; Neumann RS; Lundin KEA; Christophersen A; Sollid LM
Mucosal Immunol; 2021 Jul; 14(4):842-851. PubMed ID: 33654213
[TBL] [Abstract][Full Text] [Related]
17. A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthood.
Tan L; Fichtner AS; Bruni E; Odak I; Sandrock I; Bubke A; Borchers A; Schultze-Florey C; Koenecke C; Förster R; Jarek M; von Kaisenberg C; Schulz A; Chu X; Zhang B; Li Y; Panzer U; Krebs CF; Ravens S; Prinz I
Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33893173
[TBL] [Abstract][Full Text] [Related]
18. The γδ T cells dual function and crosstalk with intestinal flora in treating colorectal cancer is a promising area of study.
Lin P; Yan Y; Zhang Z; Dong Q; Yi J; Li Q; Zhang A; Kong X
Int Immunopharmacol; 2023 Oct; 123():110733. PubMed ID: 37579540
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
Story JY; Zoine JT; Burnham RE; Hamilton JAG; Spencer HT; Doering CB; Raikar SS
Cytotherapy; 2021 Jan; 23(1):12-24. PubMed ID: 33168453
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity.
Siegers GM; Dutta I; Kang EY; Huang J; Köbel M; Postovit LM
Front Immunol; 2020; 11():1287. PubMed ID: 32636849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
